Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings an investment of…

PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a). With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and patient-focused approach can help it meet the…

An African Union effort to strengthen public health and improve vaccine access in Africa has received a $45 million financing package. The U.S. International Development Finance Corporation, the African Development Bank and the International Finance Corporation (IFC) jointly announced the package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). This agreement underscores…

Press release: Southampton, PA – NewAge Industries, Inc., parent company of AdvantaPure™ and NewAge Performance Products, a global leader in fluid transfer systems solutions for the biopharma and industrial markets, is pleased to announce the appointment of Mary Marcus to the position of CEO. “Since her arrival in 2008, Mary has been a vital part…

Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership with Eva Pharma. The companies launched their collaboration in 2022 to deliver a sustainable supply of high-quality, affordable human and analog insulin. It wants to bring insulin to at least 1 million people annually living with diabetes in low- to…

Novo Nordisk announced today that it plans to invest $1.2 billion (8.5 billion Danish kroner) in a new production facility in Odense, Denmark. The company said this marks the first time in this century that it breaks ground in Denmark by establishing a new production site. Novo Nordisk plans to include a state-of-the-art finished production…

CellProthera announced a deal with Shonan Kamakura General Hospital (SKGH) to transfer technology to enable cell therapy manufacturing for clinical trials. The memorandum of understanding allows for GMP manufacturing of CD34+ endothelial progenitor cells (EPCs) for autologous therapy clinical trials. Takayuki Asahara of SKGH intends to adopt CellProthera’s StemXpand platform for clinical trials starting next…

Siemens Healthineers announced today that it completed the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis. The newly acquired unit is a European manufacturing and distribution network of diagnostic radiopharmaceuticals for positron emission tomography (PET) scans. According to a news release, it will be known as “Advanced Accelerator Applications, a Siemens Healthineers company.” Reports first…

Eli Lilly (NYSE:LLY) announced that it plans to invest $3 billion in the expansion of its manufacturing facility in Kenosha County, Wisconsin. In April, Indianapolis-based Eli Lilly acquired the plant in Pleasant Prairie, Wisconsin, from sterile manufacturer Nexus. The company expects its investment to extend its global parenteral (injectable) product manufacturing network. It aims to…

Novavax announced today that it signed a definitive agreement to sell a European manufacturing plant to Novo Nordisk for $200 million. The agreement centers around the company’s facility in Bohumil, Czech Republic, about 25 miles outside of Prague. It includes a transfer of assets, including a 150,000-square-foot, state-of-the-art recombinant protein manufacturing facility. That includes support…